Brain study seeks to unravel emotional thinking in depressed older adults
NCT ID NCT05966532
First seen Jun 25, 2026 · Last updated Jul 31, 2026 · Updated 4 times
Summary
This study looks at how older adults with major depression handle emotions and make choices compared to healthy adults. Researchers will use brain scans and computer tasks to measure emotional recognition, reward processing, and impulsivity. The goal is to better understand the brain mechanisms behind depression in aging, which could guide future treatments.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could help identify specific cognitive and brain patterns linked to depression in older adults, pointing toward better diagnostic tools or targeted therapies.
- What could go wrong
- This is an early-stage observational study, not a treatment trial. It may not lead to direct clinical changes, and results may not apply to all people with depression.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 276 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Dec 2023
- Expected to finish
-
Aug 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Investigators will study 120 participants aged 21-80 years old with major depressive disorder (MDD). Participants with MDD will undergo clinical and neurocognitive assessment, and MEG/MRI procedures at one time point. Investigators team will also enroll 120 demographically matched comparable, never-depressed healthy participants (controls) to establish cognitive benchmarks. Healthy controls will complete clinical and neurocognitive measures at one time point. To attain a balanced sample of adults across the lifespan, research teams will enroll participants such that each age epoch (e.g., 21-30, 31-40, etc.) has a total of ten subjects (n=10) in both the healthy control cohort and depressed cohort.
- Ages
-
21 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Male and female participants 2. Age between 21-80 years old 3. DSM-5 diagnosis of major depressive disorder (MDD) based on Mini Neuropsychiatric Interview 4. Inventory of Depressive Symptomatology-Clinician Rated version (IDS-C) total score \> 14 5. Able to read, write, and comprehend English 6. Provide informed consent; willing to comply with study protocol Exclusion Criteria: 1. History of bipolar disorder, schizophrenia, or schizoaffective disorder 2. Presence of psychotic features 3. Lifetime central nervous system (CNS) disease (including head injury with loss of consciousness \> 5 minutes) 4. History of neurodevelopmental disorder (e.g., Autism spectrum disorder) 5. History of medical conditions that can affect neurocognitive function as well as be confounded with age (e.g., thyroid disease, endocrine illnesses) 6. Women who are pregnant 7. Current use of medications with known impacts on neurocognitive function (e.g., acetylcholinesterase inhibitors, amphetamine, methylphenidate, vortioxetine, sedatives) 8. Alcohol/substance use disorder within past 3 months 9. DSM-5 diagnosis of major cognitive impairment 10. Current sensory or physical impairment that interferes with testing. 11. Contraindication to MRI and MEG (only for depressed participants) (e.g., any electronic / metallic implants near or within the head or body, claustrophobia)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Healthy adult volunteer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Texas Arlington
Arlington, Texas, 76010, United States
-
University of Texas Southwestern Medical Center
Dallas, Texas, 75390-9127, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gut bacteria may hold clues to dozens of diseases
- Zapping the Brain's fear center: a new approach to depression
- Can a structured care pathway lift teen depression in primary care?
- Can Anti-Inflammatory drugs lift depression that Won't budge?
- A brain stimulation trial aims to rewire the circuit behind depression
- Can pairing ketamine with talk therapy beat depression alone?